Ryvu Therapeutics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	59.61	160.07	57.94	101.92	83.24
Short-Term Investments	48.07	65.86	175.73	0.53	4.99
Cash & Short-Term Investments	107.68	225.93	233.67	102.45	88.23
Cash Growth	-52.34%	-3.31%	128.09%	16.11%	-45.26%
Accounts Receivable	10.6	15.66	9.19	1.05	5.94
Other Receivables	9.5	20.12	23.65	258.85	5.8
Receivables	20.1	35.78	32.84	259.89	11.74
Inventory	1.34	1.21	2.12	1.76	1.96
Prepaid Expenses	-	-	-	2.35	1.63
Other Current Assets	10.14	9.52	9.77	1.48	0.69
Total Current Assets	139.25	272.44	278.39	367.93	104.25
Property, Plant & Equipment	70.02	72.74	77.56	82.22	91.18
Long-Term Investments	6.38	16.77	34.37	20.48	29.4
Other Intangible Assets	6.04	8.12	6.34	4.28	3.04
Long-Term Deferred Tax Assets	-	-	-	-	0.33
Other Long-Term Assets	2.75	8.72	6.55	0.08	0.6
Total Assets	224.44	378.78	403.2	474.98	228.81
Accounts Payable	16.23	31.15	23.14	12.58	11.69
Accrued Expenses	3.74	12.28	12.22	11.7	4.86
Short-Term Debt	0.11	0.29	0.13	0.06	0.02
Current Portion of Long-Term Debt	16.08	25.79	-	0.81	0.81
Current Portion of Leases	0.38	0.5	0.41	1.03	1.92
Current Income Taxes Payable	-	-	-	-	5.46
Current Unearned Revenue	23.19	35.71	31.53	16.71	8.95
Other Current Liabilities	1.86	2.21	2.27	1.93	2.5
Total Current Liabilities	61.58	107.93	69.7	44.81	36.2
Long-Term Debt	78.38	74.15	8.85	9.9	8.86
Long-Term Leases	0.96	1.39	0.37	0.87	1.58
Long-Term Unearned Revenue	29.5	42.74	64.26	75.8	20.26
Pension & Post-Retirement Benefits	0.18	0.28	0.43	0.14	0.12
Long-Term Deferred Tax Liabilities	-	-	-	-	0.44
Other Long-Term Liabilities	-	-	-	0.06	0.06
Total Liabilities	170.6	226.48	143.61	131.59	67.51
Common Stock	9.25	9.25	9.25	7.34	7.34
Additional Paid-In Capital	519.75	519.75	519.75	279.06	279.06
Retained Earnings	-212.67	-111.44	-0.01	92.1	175.88
Comprehensive Income & Other	-262.49	-265.26	-269.39	-35.12	-300.99
Total Common Equity	53.83	152.29	259.59	343.39	161.3
Shareholders' Equity	53.83	152.29	259.59	343.39	161.3
Total Liabilities & Equity	224.44	378.78	403.2	474.98	228.81
Total Debt	95.9	102.12	9.76	12.67	13.19
Net Cash (Debt)	11.78	123.81	223.91	89.77	75.04
Net Cash Growth	-90.49%	-44.71%	149.42%	19.63%	-51.20%
Net Cash Per Share	0.51	5.36	9.78	4.89	4.09
Filing Date Shares Outstanding	23.12	23.12	23.12	23.12	18.36
Total Common Shares Outstanding	23.12	23.12	23.12	23.12	18.36
Working Capital	77.67	164.51	208.69	323.12	68.05
Book Value Per Share	2.33	6.59	11.23	14.85	8.79
Tangible Book Value	47.79	144.18	253.26	339.11	158.26
Tangible Book Value Per Share	2.07	6.24	10.95	14.67	8.62
Land	7.47	7.47	7.47	7.47	7.47
Buildings	52.28	52.21	52.2	52.15	53
Machinery	15.79	16.09	15.38	14.15	13.8
Construction In Progress	-	0.35	-	-	0.61

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.